A deficiency in levels of the neurotransmitter acetylcholine (ACh) has been observed in the brains of AD patients, and inhibition of acetylcholinesterase (AChE), the key enzyme which hydrolyses ACh, is a major treatment option for AD [15]. Here, ACHE is linked to Alzheimer disease.